We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House and Senate will each take a hard look at drug prices Tuesday, one in a mark-up that would require drugmakers to make public justifications for price increases or high launch prices, the other in a hearing that will gather executives from some of the nation’s largest pharmacy benefit managers.